EPB41L5
Basic information
Region (hg38): 2:120013076-120179119
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the EPB41L5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 40 | 43 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 40 | 6 | 0 |
Variants in EPB41L5
This is a list of pathogenic ClinVar variants found in the EPB41L5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-120019100-C-T | not specified | Uncertain significance (Apr 22, 2024) | ||
2-120019108-A-G | Likely benign (Apr 01, 2022) | |||
2-120019118-C-T | not specified | Uncertain significance (Feb 26, 2024) | ||
2-120019119-G-A | not specified | Uncertain significance (Dec 21, 2023) | ||
2-120019128-G-A | Uncertain significance (Jul 01, 2022) | |||
2-120019139-G-A | not specified | Uncertain significance (Jan 31, 2023) | ||
2-120019155-G-A | not specified | Uncertain significance (Jan 24, 2023) | ||
2-120019167-G-A | not specified | Uncertain significance (Aug 30, 2022) | ||
2-120019172-G-A | not specified | Uncertain significance (Dec 18, 2023) | ||
2-120019215-C-T | not specified | Uncertain significance (Feb 06, 2024) | ||
2-120019241-A-G | not specified | Uncertain significance (Nov 29, 2023) | ||
2-120042033-G-A | not specified | Uncertain significance (Jul 20, 2021) | ||
2-120042090-A-G | not specified | Uncertain significance (May 04, 2022) | ||
2-120073199-A-C | not specified | Uncertain significance (Jan 31, 2022) | ||
2-120074112-A-G | not specified | Uncertain significance (Mar 22, 2023) | ||
2-120074169-A-C | not specified | Uncertain significance (Dec 20, 2023) | ||
2-120076976-C-G | not specified | Uncertain significance (Jul 19, 2023) | ||
2-120077036-C-G | not specified | Uncertain significance (Dec 19, 2022) | ||
2-120077047-T-C | Likely benign (Jun 01, 2022) | |||
2-120077247-G-C | not specified | Uncertain significance (Aug 18, 2021) | ||
2-120078497-G-C | not specified | Uncertain significance (Aug 13, 2021) | ||
2-120091602-C-T | not specified | Uncertain significance (May 04, 2023) | ||
2-120100270-G-A | not specified | Likely benign (Aug 10, 2021) | ||
2-120100273-A-G | not specified | Uncertain significance (Dec 07, 2021) | ||
2-120100279-C-G | not specified | Uncertain significance (Apr 12, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
EPB41L5 | protein_coding | protein_coding | ENST00000263713 | 24 | 166115 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0208 | 0.979 | 125711 | 0 | 37 | 125748 | 0.000147 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.155 | 386 | 395 | 0.978 | 0.0000206 | 4788 |
Missense in Polyphen | 116 | 155.44 | 0.74625 | 1837 | ||
Synonymous | -0.109 | 143 | 141 | 1.01 | 0.00000733 | 1399 |
Loss of Function | 4.73 | 13 | 48.6 | 0.268 | 0.00000277 | 555 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000154 | 0.000152 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000221 | 0.000217 |
Finnish | 0.000139 | 0.000139 |
European (Non-Finnish) | 0.000186 | 0.000185 |
Middle Eastern | 0.000221 | 0.000217 |
South Asian | 0.000199 | 0.000196 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May contribute to the correct positioning of tight junctions during the establishment of polarity in epithelial cells. {ECO:0000269|PubMed:17920587}.;
- Pathway
- Endoderm Differentiation;Mesodermal Commitment Pathway;Neuronal System;Neurexins and neuroligins;Protein-protein interactions at synapses
(Consensus)
Recessive Scores
- pRec
- 0.0911
Intolerance Scores
- loftool
- 0.0844
- rvis_EVS
- 0.05
- rvis_percentile_EVS
- 57.48
Haploinsufficiency Scores
- pHI
- 0.194
- hipred
- N
- hipred_score
- 0.443
- ghis
- 0.494
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.349
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Epb41l5
- Phenotype
- digestive/alimentary phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; embryo phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); hematopoietic system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype;
Zebrafish Information Network
- Gene name
- epb41l5
- Affected structure
- retinal ganglion cell
- Phenotype tag
- abnormal
- Phenotype quality
- increased distribution
Gene ontology
- Biological process
- in utero embryonic development;epithelial to mesenchymal transition;neural plate morphogenesis;apical constriction;substrate-dependent cell migration, cell attachment to substrate;ectoderm development;endoderm development;mesoderm migration involved in gastrulation;unidimensional cell growth;posttranscriptional regulation of gene expression;positive regulation of epithelial cell migration;positive regulation of epithelial to mesenchymal transition;negative regulation of cell-cell adhesion;actomyosin structure organization;negative regulation of protein binding;positive regulation of protein binding;somite rostral/caudal axis specification;axial mesoderm morphogenesis;paraxial mesoderm development;embryonic foregut morphogenesis;positive regulation of focal adhesion assembly;regulation of establishment of protein localization;left/right axis specification;cellular response to transforming growth factor beta stimulus
- Cellular component
- nucleus;cytosol;cytoskeleton;plasma membrane;focal adhesion;ruffle membrane
- Molecular function
- cytoskeletal protein binding;protein domain specific binding